. Author manuscript; available in PMC: 2019 Nov 29.

Published in final edited form as: Mol Psychiatry. 2019 May 28;26(3):761–771. doi: 10.1038/s41380-019-0428-y

Table 1:

Sample demographic and clinical characteristics.

	Control (n=40)	Schizophrenia (n=36)
Age: mean (SD)	21.9 (2.8)	21.4 (3.4)
Gender: number Male/Female	27 / 13	25 / 11
Education: mean (SD)	14.3 (2.6)	12.5 (1.9)^*
Parental Education: mean (SD)	14.7 (3.5)	14.4 (2.9)
WASI: mean (SD)	115.8 (12.3)	104.6 (18.6)^*
Diagnosis: (n)
Schizophreniform	-	3
Schizophrenia	-	18
Schizoaffective	-	15
Antipsychotic Dose: mean CPZ equivalent (SD)	-	226.64 (168.7)
SANS	-	11.2 (3.6)
SAPS	-	4.4 (3.4)
BPRS	-	46.8 (12.0)
Global Functioning: Social	-	6.1 (1.5)
Global Functioning: Role	-	3.5 (2.5)

SD: Standard Deviation; WASI: Wechsler Abbreviated Scale of Intelligence; CPZ: chlorpromazine; SANS: Scale for the Assessment of Negative Symptoms; SAPS: Scale for the Assessment of Positive Symptoms; BPRS: Brief Psychiatric Rating Scale.

p<.05.